Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status
- PMID: 1312892
- DOI: 10.1002/1097-0142(19920401)69:7<1739::aid-cncr2820690715>3.0.co;2-9
Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status
Abstract
Argyrophilic nucleolar organizer regions (AgNOR) have been correlated with proliferative activity of neoplasms. Increased AgNOR may reflect increased proliferative activity of cells or ploidy. To explore this hypothesis, 41 breast carcinomas were processed for AgNOR silver staining and DNA flow cytometry. AgNOR counts were expressed as mean AgNOR/nucleus and percentage of tumor cells with more than five AgNOR/nucleus. The first count was designated mean AgNOR or mAgNOR, and the second count was designated AgNOR proliferative index or pAgNOR. Using Mantel-Haensel statistical analysis, carcinomas that exhibited mAgNOR of 2.4 or more had a high likelihood of aneuploidy (P less than 0.0001), an S-phase fraction of more than 5.8% (P less than 0.003), or a diameter greater than 2 cm (P less than 0.007). In addition, tumors with pAgNOR of 8% or more showed a statistically significant correlation with aneuploidy (P less than 0.004), tumor grade (P less than 0.04), and a more significant one with high S-phase fraction (P less than 0.0001). No significant correlation was obtained between pAgNOR and tumor size or lymph node status. These data indicate that AgNOR quantitation reflects changes in DNA ploidy and cell proliferation. They also suggest that the mean AgNOR counts correlate best with the DNA mass or ploidy and that the frequency of cells with higher AgNOR count best reflects proliferative activity or S-phase fraction.
Similar articles
-
Two AgNOR counts in fine-needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry.Diagn Cytopathol. 1992;8(2):128-34. doi: 10.1002/dc.2840080208. Diagn Cytopathol. 1992. PMID: 1568410
-
The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique.Cancer. 1994 Sep 15;74(6):1739-45. doi: 10.1002/1097-0142(19940915)74:6<1739::aid-cncr2820740616>3.0.co;2-t. Cancer. 1994. PMID: 8082076
-
The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.Hum Pathol. 1993 Feb;24(2):206-10. doi: 10.1016/0046-8177(93)90302-w. Hum Pathol. 1993. PMID: 8432516
-
Standardized AgNOR analysis: its usefulness in surgical oncology.Histochem Cell Biol. 1996 Aug;106(2):193-6. doi: 10.1007/BF02484400. Histochem Cell Biol. 1996. PMID: 8877379 Review.
-
Are DNA flow cytometry measurements providing useful information in the management of the node-negative breast cancer patient?Cancer Invest. 1992;10(5):477-86. doi: 10.3109/07357909209024806. Cancer Invest. 1992. PMID: 1393694 Review.
Cited by
-
Measuring proliferation in breast cancer: practicalities and applications.Breast Cancer Res. 2006;8(6):216. doi: 10.1186/bcr1618. Breast Cancer Res. 2006. PMID: 17164010 Free PMC article. Review.
-
Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.Postgrad Med J. 2003 Oct;79(936):569-74. doi: 10.1136/pmj.79.936.569. Postgrad Med J. 2003. PMID: 14612599 Free PMC article. Review.
-
The prognostic significance of epidermal growth factor receptor expression in breast cancer.Surg Today. 1994;24(10):889-94. doi: 10.1007/BF01651004. Surg Today. 1994. PMID: 7894186
-
Interphase cytogenetic and AgNOR analyses of hydatidiform moles.J Clin Pathol. 1998 Jun;51(6):438-43. doi: 10.1136/jcp.51.6.438. J Clin Pathol. 1998. PMID: 9771442 Free PMC article.
-
Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast Carcinoma.Patholog Res Int. 2011;2011:237217. doi: 10.4061/2011/237217. Epub 2011 Nov 1. Patholog Res Int. 2011. PMID: 22135766 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical